Table 1. Relationship between expression of miR-195, Cyclin D1, and Bcl-2 and clinicopathologic factors in 81 TSCC patients.

		miR-195 (T/N)		Cyclin D1(% )			Bcl-2 (% )
Characteristics	No.	Mean ± SD	P	No. of low expression	No. of high expression	P	No. of low expression	No. of high expression	P
Sex			0.739			0.397			0.250
Male	45	0.625±0.623		22	23		27	18
Female	36	0.674±0.693		21	15		26	10
Age			0.321			0.397			0.105
<60 y	45	0.708±0.762		22	23		26	19
≥60 y	36	0.570±0.502		21	15		27	9
Tumor size			0.005			0.023			0.254
T1–T2	53	0.772±0.762		33	20		37	16
T3–T4	28	0.425±0.297		10	18		16	12
Differentiation			0.747			0.932			0.608
Well	35	0.709±0.753		18	17		23	12
Moderate	38	0.592±0.590		21	17		26	12
Poor	8	0.687±0.582		4	4		4	4
Clinical stage			0.019			0.491			0.778
I–II	48	0.780±0.770		27	21		32	16
III–IV	33	0.466±0.394		16	17		21	12
Node metastasis			0.493			0.056			0.488
Yes	42	0.603±0.592		18	24		26	16
No	39	0.705±0.728		25	14		27	12
Status			0.010			0.254			0.088
Survival	48	0.810±0.755		28	20		35	13
Death	33	0.433±0.418		15	18		18	15

Abbreviations: T, tumor; N, nonmalignant tissue; T1–T4: T stage of TNM classification system.